Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Confluence Discovery Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Confluence Discovery Technologies

Confluence Discovery Technologies

Seed

Confluence Discovery Technologies: Expertise in drug discovery and clinical development services.

HQ
St. Louis, MO, US
Founded
2010
Overview
Compare
Fundraising
Employees

Confluence Discovery Technologies focuses on providing advanced drug discovery and clinical development services. With extensive experience in the pharmaceutical industry, the company assists in various phases of the discovery process, aiming to accelerate the development of new therapeutics.

The company has achieved significant milestones in drug development, contributing to the advancement of several clinical candidates. Its impact is marked by successful collaborations and partnerships within the biotech and pharmaceutical sectors.

Confluence Discovery Technologies - Similar Companies

Discovery Innovations logo

Discovery Innovations

Confluence Pharmaceuticals logo

Confluence Pharmaceuticals

Kalypsys logo

Kalypsys

kalypsys.com

Trana Discovery logo

Trana Discovery

Lakeside Discovery logo

Lakeside Discovery

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Radyus Research logo

Radyus Research

radyusresearch.com

The Concinnity Company logo

The Concinnity Company

Edis Solutions logo

Edis Solutions

Ligon Discovery logo

Ligon Discovery

Data2Discovery logo

Data2Discovery

d2discovery.com

Kumuda logo

Kumuda

kumuda.org

Transparency Life Sciences logo

Transparency Life Sciences

Ensemble Discovery logo

Ensemble Discovery

Collaborations Pharmaceuticals logo

Collaborations Pharmaceuticals

Confluence Discovery Technologies - Quick Facts

Who are Confluence Discovery Technologies' competitors?

Companies similar to Confluence Discovery Technologies include Discovery Innovations, Confluence Pharmaceuticals, Kalypsys and Trana Discovery.

When was Confluence Discovery Technologies founded?

Confluence Discovery Technologies was founded in 2010.

Where is Confluence Discovery Technologies' headquarters located?

Confluence Discovery Technologies' headquarters is located in St. Louis, MO, US.

When was Confluence Discovery Technologies' last funding round?

Confluence Discovery Technologies' most recent funding round was for $75k (USD) in January 2011.

How much has Confluence Discovery Technologies raised to-date?

As of Jan 1, 2011, Confluence Discovery Technologies has raised a total of $75k (USD).

How many employees does Confluence Discovery Technologies have?

Confluence Discovery Technologies has 40 employees as of Feb 4, 2024.

Confluence Discovery Technologies - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Clinical Development
  • Drug Discovery
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified